ARC Healthcare shareholders will receive .1688 shares of Ventas (a Ventas share value of $67.13) or, if elected, $11.33 per share of ARC Healthcare owned. The cash portion of the acquisition will be limited to 10% of ARC Healthcare’s outstanding shares.
ARC Healthcare closed the program to new investors on April 12, 2013 and listed the shares on the Nasdaq on April 7, 2014.
The boards of both companies have unanimously approved the Ventas purchase. A closing date for the acquisition has not been provided.